COMMUNIQUÉS West-GlobeNewswire

Betterguards Unveils New Sports Tech, The BetterGuard 2.0
31/07/2024
Intelligent ankle brace technology offers preventative support against common ankle injuries NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Betterguards , a next-generation sports technology innovator, announces the launch [...]
20 Facilities Ranked as the 2024 Most Beautiful Hospitals in the U.S.
31/07/2024
Hospitals chosen for their exceptional facilities, staff and patient experience in contest hosted by national staffing firm Soliant ATLANTA, July 31, 2024 (GLOBE NEWSWIRE) -- National staffing firm Soliant today named [...]
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
31/07/2024
Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal [...]
Natural Harmony Foods Inc. Completes Financial Audits for 2022 & 2023
31/07/2024
Unlocking Funds to Accelerate Operations NEW YORK, July 31, 2024 (GLOBE NEWSWIRE) -- Publicly-held Natural Harmony Foods Inc. (OTC: NHYF) is delighted to report the completion of its financial statement audits for the [...]
Palisade Bio Participates in Virtual Investor “What this Means” Segment
31/07/2024
Mitch Jones, MD, PhD, CMO of Palisade Bio highlights recent findings from a microbiome study confirming local bioactivation of lead product candidate, PALI-2108 Carlsbad, CA, July 31, 2024 (GLOBE NEWSWIRE) -- Palisade [...]
Rhythm Pharmaceuticals Announces European Commission Expands ▼IMCIVREE® (setmelanotide) Marketing Authorization to include Children as Young as 2 Years Old
31/07/2024
IMCIVREE now authorized as treatment of obesity and control of hunger in adult patients and pediatric patients 2 years old or older with Bardet Biedl syndrome or POMC, PCSK1, or LEPR deficiency BOSTON, July 31, 2024 ( [...]
Arch Biopartners Closes Non-Brokered Private Placement
30/07/2024
TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has closed the non-brokered private placement disclosed in a press [...]
TRACON Pharmaceuticals Announces it Will Wind Down Operations
30/07/2024
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was made at a special [...]
DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
30/07/2024
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrollment in peanut [...]
DBV Technologies présente les dernières avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et les tout-petits de 1 à 3 ans et publie ses résultats financiers du deuxième trimestre et premier semestre 2024.
30/07/2024
DBV Technologies présente les dernières avancées du programme Viaskin Peanut chez les enfants de 4 à 7 ans et les tout-petits de 1 à 3 ans et publie ses résultats financiers du deuxième trimestre et premier semestre [...]
MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024
30/07/2024
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , announced today that it will report its second quarter 2024 financial results before the market opens [...]
Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024
30/07/2024
MINNEAPOLIS, July 30, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical [...]
MacroGenics Provides Vobramitamab Duocarmazine Update
30/07/2024
Abstract of clinical data accepted for poster presentation at ESMO Congress 2024 in September ESMO poster to include protocol-defined TAMARACK Phase 2 mCRPC study data, including pre-defined landmark primary endpoint of [...]
Inari Medical Announces Chief Financial Officer Retirement and Succession Plan
30/07/2024
Mitch Hill to retire as Chief Financial Officer, to be succeeded by Kevin Strange in October 2024 IRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company [...]
Oculis to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
30/07/2024
ZUG, Switzerland, July 30, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ [...]
FibroGen to Report Second Quarter 2024 Financial Results
30/07/2024
SAN FRANCISCO, July 30, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce second quarter 2024 financial results on Tuesday, August 6 after the market close. FibroGen will also conduct a conference [...]
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
30/07/2024
CAMBRIDGE, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational [...]
Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024
30/07/2024
FREMONT, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the second quarter 2024 after [...]
Aligos Therapeutics to Announce 2nd Quarter 2024 Financial Results on August 6, 2024
30/07/2024
SOUTH SAN FRANCISCO, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]

Pages